Cargando…

The diphenylpyrazole compound anle138b blocks Aβ channels and rescues disease phenotypes in a mouse model for amyloid pathology

Alzheimer's disease is a devastating neurodegenerative disease eventually leading to dementia. An effective treatment does not yet exist. Here we show that oral application of the compound anle138b restores hippocampal synaptic and transcriptional plasticity as well as spatial memory in a mouse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinez Hernandez, Ana, Urbanke, Hendrik, Gillman, Alan L, Lee, Joon, Ryazanov, Sergey, Agbemenyah, Hope Y, Benito, Eva, Jain, Gaurav, Kaurani, Lalit, Grigorian, Gayane, Leonov, Andrei, Rezaei‐Ghaleh, Nasrollah, Wilken, Petra, Arce, Fernando Teran, Wagner, Jens, Fuhrman, Martin, Caruana, Mario, Camilleri, Angelique, Vassallo, Neville, Zweckstetter, Markus, Benz, Roland, Giese, Armin, Schneider, Anja, Korte, Martin, Lal, Ratnesh, Griesinger, Christian, Eichele, Gregor, Fischer, Andre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760857/ https://www.ncbi.nlm.nih.gov/pubmed/29208638 http://dx.doi.org/10.15252/emmm.201707825

Ejemplares similares

Anle138b modulates α‐synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy
por: Heras‐Garvin, Antonio, et al.
Publicado: (2018)

Anle138b Partly Ameliorates Motor Deficits Despite Failure of Neuroprotection in a Model of Advanced Multiple System Atrophy
por: Fellner, Lisa, et al.
Publicado: (2016)

The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset
por: Levin, Johannes, et al.
Publicado: (2014)

The clinical drug candidate anle138b binds in a cavity of lipidic α-synuclein fibrils
por: Antonschmidt, Leif, et al.
Publicado: (2022)

Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies
por: Wagner, Jens, et al.
Publicado: (2015)

Targeting α-synuclein by PD03 AFFITOPE® and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevance
por: Lemos, Miguel, et al.
Publicado: (2020)

Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease
por: Wagner, Jens, et al.
Publicado: (2013)

Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer’s disease tau
por: Brendel, Matthias, et al.
Publicado: (2019)

The small molecule inhibitor anle145c thermodynamically traps human islet amyloid peptide in the form of non-cytotoxic oligomers
por: Saravanan, Manikam S., et al.
Publicado: (2019)

Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial
por: Levin, Johannes, et al.
Publicado: (2022)

(11)C Radiolabeling of anle253b: a Putative PET Tracer for Parkinson's Disease That Binds to α‐Synuclein Fibrils in vitro and Crosses the Blood‐Brain Barrier
por: Maurer, Andreas, et al.
Publicado: (2020)

Therapeutic Trial of anle138b in Mouse Models of Genetic Prion Disease
por: Vallabh, Sonia M., et al.
Publicado: (2023)

In Silico Study of the Interactions of Anle138b Isomer, an Inhibitor of Amyloid Aggregation, with Partner Proteins
por: Kondratyev, Maxim S., et al.
Publicado: (2022)

Mechanism of action deconvolution of the small-molecule pathological tau aggregation inhibitor Anle138b
por: Hosseini-Gerami, Layla, et al.
Publicado: (2023)

Synthesis and Preliminary Characterization of Putative Anle138b-Centered PROTACs against α-Synuclein Aggregation
por: Pedrini, Martina, et al.
Publicado: (2023)

Reorientational Dynamics of Amyloid-β from NMR Spin Relaxation and Molecular Simulation
por: Rezaei-Ghaleh, Nasrollah, et al.
Publicado: (2019)

Metal Binding to Sodium Heparin Monitored by Quadrupolar NMR
por: Sieme, Daniel, et al.
Publicado: (2022)

ANL/WSU radiation damage studies
por: Jankowski, D, et al.
Publicado: (1993)

Neutrino interactions at ANL, BNL, and CERN
por: Musset, P
Publicado: (1974)

Iron-mediated aggregation and toxicity in a novel neuronal cell culture model with inducible alpha-synuclein expression
por: Bartels, Martin, et al.
Publicado: (2019)

L'approche neurolinguistique (ANL) : foire aux questions /
por: Germain, Claude
Publicado: (2017)

Structural Plasticity in Human Heterochromatin Protein 1β
por: Munari, Francesca, et al.
Publicado: (2013)

Phosphorylation modifies the molecular stability of β-amyloid deposits
por: Rezaei-Ghaleh, Nasrollah, et al.
Publicado: (2016)

Discovery of Compounds That Selectively Repress the Amyloidogenic Processing of the Amyloid Precursor Protein: Design, Synthesis and Pharmacological Evaluation of Diphenylpyrazoles
por: Mesangeau, Christophe, et al.
Publicado: (2022)

Molecular Diffusivity of Click Reaction Components: The Diffusion Enhancement Question
por: Rezaei-Ghaleh, Nasrollah, et al.
Publicado: (2022)

Response to Comment on “Following Molecular Mobility during Chemical Reactions: No Evidence for Active Propulsion” and “Molecular Diffusivity of Click Reaction Components: The Diffusion Enhancement Question”
por: Rezaei-Ghaleh, Nasrollah, et al.
Publicado: (2022)

Interaction between Amyloid Beta Peptide and an Aggregation Blocker Peptide Mimicking Islet Amyloid Polypeptide
por: Rezaei-Ghaleh, Nasrollah, et al.
Publicado: (2011)

Extended barrel module 0 instrumentation at ANL
por: ANL, group
Publicado: (1998)

AMU-ANL Conference on Direct Energy Conversion
por: Collective
Publicado: (1963)

Singlet-filtered NMR spectroscopy
por: Mamone, Salvatore, et al.
Publicado: (2020)

Combined High-Pressure and Multiquantum NMR and Molecular Simulation Propose a Role for N-Terminal Salt Bridges in Amyloid-Beta
por: Vemulapalli, Sahithya Phani Babu, et al.
Publicado: (2021)

Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization
por: Dominguez-Meijide, Antonio, et al.
Publicado: (2020)

Atlas Tile Calorimeter ANL master punching die
por: ANL, photos
Publicado: (1996)

ATLAS Tile calorimeter: ANL module0 submodules construction
por: ANL, photos
Publicado: (1999)

5th ANL/MSU/JINA/INT FRIB Workshop
por: Danielewicz, Pawel
Publicado: (2009)

A New Vanadium (III) Complex of 2,6-Bis(3,5-diphenylpyrazol-1-ylmethyl)pyridine as a Catalyst for Ethylene Polymerization
por: Abbo, Hanna S., et al.
Publicado: (2013)

Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson’s disease model
por: Wegrzynowicz, Michal, et al.
Publicado: (2019)

Low-Expressing Synucleinopathy Mouse Models Based on Oligomer-Forming Mutations and C-Terminal Truncation of α-Synuclein
por: Martinez Hernandez, Ana, et al.
Publicado: (2021)

Comparison of LED and Cs Data Signals for the ANL Optical Test Module
por: Stanek, B, et al.
Publicado: (1999)

The ANL 50 MeV H$^{-}$ Injector: 35 Year Anniversary
por: Stipp, V F, et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_qdd12b8eoatu4cvmum0edd8nba